<b>Gapping up <br/>In reaction to strong earnings/guidance:</b><br/><br/>SSTI +8%, LPSN +6.9%, KL +5.7%, QUAD +5.4%, WIRE +4.9%, LZB +4.8%, AAP +3.8%, VRSK +3.1%, FCPT +3%, MSA +3%, FE +3%, GLRE +2.8%, SO +2.8%, VPG +2.8%, NGD +2.7%, CYBE +2.7%, FLR +2.3%, HALO +2.3%, LYG +2.1%, NYMT +2%, UTHR +2%, IVR +1.8%, UVE +1.7%, TX +1.7%, OC +1.5%, ALO +1.4%, PNM +1.3%, HSTM +1.2%, HFC +1.1%, AVA +0.9%, AIMC +0.8%, VIAV +0.7%, .<br/><b>M&A news:</b><br/><br/>RAS +7% (strategic and financial alternative review process-determined that this review did not identify a suitable strategic or financial transaction with another counterparty that was preferable to the steps being reported Tuesday)<br/>FBC +1% (to acquire mortgage warehouse loan portfolio from Santander Bank)<br/><b>Other news:</b><br/><br/>TTPH +10.1% (enters into an exclusive licensing agreement with Everest Medicines to develop and commercialize eravacycline in mainland China, Taiwan, Hong Kong, Macau, South Korea, and Singapore)<br/>COGT +6.7% (Cogint and BlueFocus International terminate proposed business combination)<br/>LGCY +6.6% (10% owner Baines Creek Capital disclosed purchase of more than 450k shares worth nearly $1.1 mln)<br/>CYCC +5.8% (Cyclacel Pharma receives notice from the European Patent Office of the intention to grant a patent (EP1962814) including claims to novel pharmaceutical formulations of sapacitabine)<br/>FELE +5.3% (modestly rebounding)<br/>QTWO +2.4% (commences $200 mln private offering of convertible senior notes due 2023)<br/>ADMS +2.3% (modestly rebounding - closed 22% lower on the day<br/>TNDM +1.8% (announced its submission of a medical device license application to Health Canada to market its t:slim X2 Insulin Pump)<br/>NUVA +1.4% (SpineTRACK Registry received the designation of Qualified Clinical Data Registry by the Centers of Medicare and Medicaid Services for the 2018 Merit-based Incentive Payment System reporting year)<br/>RGR +0.9% (after President Trump spoke with reporters says he just signed memo to order Justice Department to ban 'bump stock' devices for guns), . <br/><b>Analyst comments:</b><br/><br/>MOS +2.6% (upgraded to Overweight from Neutral at JP Morgan)<br/>THRM +1.6% (upgraded to Buy from Hold at Craig Hallum)<br/>PANW +1.3% (upgraded to Positive from Neutral at Susquehanna)<br/><b>Gapping down<br/>In reaction to disappointing earnings/guidance:</b><br/><br/>RCII -15.5%, CATM -13.3%, LC -9.7%, DVN -7.6%, TTS -6.5%, INOV -5.5%, LHO -5.1%, SLCA -4.9%, BYD -4.5%, QTS -4.5%, TXRH -4.2%, MATX -4%, IPHS -2.3%, PSA -1.8%, EROS -1.5%, CHEF -1.3%, FTK -1.1%, NFX -1.1%<br/><b>M&A news:</b><br/><br/>ANW -10.1% (to acquire H.E.C. Europe Limited for approx $367 mln including the assumption of certain indebtedness; expects to be immediately accretive to adjusted EPS)<br/><b>Other news:</b><br/><br/>PTLA -8.8% (Portola Pharma announces CHMP communicated positive trend vote on Marketing Authorisation Application for andexanet alfa and negative trend vote for betrixaban)<br/>RIOT -4% (cont weakness)<br/>AIMT -2.7% (commenced an underwritten public offering of $150 mln of shares of common stock)<br/>SHOP -2.6% (launches offering of 4,800,000 Class A subordinate voting shares )<br/>PENN -1.4% (following BYD results)<br/>ASND -1.3% (commenced an underwritten public offering of $150,000,000 of American Depositary Shares )<br/>SIEN -0.7% (entered into $50 mln At-The-Market Equity Offering Sales Agreement with Stifel)<br/><b>Analyst comments:</b><br/><br/>BHP -1% (downgraded to Neutral at Citigroup)<br/>REGN -0.8% (downgraded to Hold from Buy at Canaccord Genuity)<br/><br/>Briefing.com